About SIGMA

SIGMA started operations in 2024 as a Full Service CRO providing high-quality services for Phase I-IV and BE studies.

Our team has vast experience in conducting clinical trials in the following main therapeutic areas:

• • Oncology
  • Hematology
  • Pulmonology
  • Cardiovascular
  • Endocrinology
  • Neurology
  • Dermatology
  • Vaccines
  • Gastroenterology
  • Ophthalmology
  • Rheumatology
  • Pediatrics
  • Infectious Diseases
  • Healthy volunteers